Welcome to our dedicated page for Algorhythm Holdings SEC filings (Ticker: RIME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Algorhythm Holdings, Inc. (NASDAQ: RIME) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, including Forms 10-K, 10-Q, 8-K, proxy statements, and registration statements. Algorhythm is a smaller reporting company that has transitioned into an AI logistics and distribution business centered on SemiCab, and its filings provide detailed insight into this transformation, its capital structure, and its risk profile.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review Algorhythm’s financial statements, segment information related to SemiCab, and discussions of material weaknesses, liquidity, and operating performance. Current reports on Form 8-K document key events such as the sale of the legacy Singing Machine karaoke business, the acquisition of SMCB Solutions Private Limited to expand SemiCab in India, the launch of the Apex SaaS platform, changes in independent registered public accounting firms, director and officer appointments and resignations, and stockholder votes on matters like reverse stock split authority, reincorporation, and equity incentive plan amendments.
Registration statements on Form S-1 and S-1/A describe Algorhythm’s arrangements with investors such as Streeterville Capital, LLC, including pre-paid purchase structures, commitment shares, and resale registration for common stock and warrants. These documents outline potential dilution, use of proceeds, and the company’s status as a smaller reporting company. Proxy materials on Schedule 14A provide additional context on corporate governance, board composition, and stockholder proposals.
On Stock Titan, Algorhythm’s filings are supplemented with AI-powered summaries that explain the significance of lengthy documents, highlight major changes from prior periods, and flag items that may affect shareholders, such as financing terms, auditor changes, and governance actions. Real-time updates from EDGAR ensure that new 8-Ks, 10-Qs, and 10-Ks appear promptly, while Form 4 insider transaction reports, when filed, can help users track equity awards and share activity by directors and officers. By using these tools, investors can navigate Algorhythm’s evolving AI logistics strategy, capital markets activity, and compliance record without reading every line of each filing.
Algorhythm Holdings, Inc. (RIME) filed a prospectus to register the resale of up to 10,095,694 shares of common stock by Streeterville Capital, LLC. The registered shares include 95,694 commitment shares already issued and up to 10,000,000 additional shares that may be issued under a pre‑paid purchase facility. The company will not receive any proceeds from Streeterville’s resale of these shares.
Under the Securities Purchase Agreement, Algorhythm may conduct one or more pre‑paid purchases for an aggregate purchase price of up to $20,000,000. Streeterville may, at its discretion, acquire shares against outstanding balances at a purchase price equal to 90% of the lowest 10‑day VWAP, subject to a floor price defined as the greater of 20% of the Nasdaq “Minimum Price” or $0.10, a 9.99% beneficial ownership cap, and Nasdaq Listing Rule 5635(d) limits unless shareholder approval is obtained. The plan of distribution permits sales via brokers, private transactions, or dealer transactions.
Shares outstanding were 2,641,778 as of September 29, 2025; the table shows up to 12,641,778 shares outstanding after the offering. The prospectus highlights risks including potential dilution and selling pressure from resales, and discloses prior losses and an auditor’s going‑concern explanatory paragraph for the year ended December 31, 2024.
Algorhythm Holdings, Inc. (RIME) filed Amendment No. 1 to Form S-1 with two prospectuses: a resale and a public offering. The resale prospectus registers up to 10,095,694 shares of common stock for Streeterville Capital, LLC, including 95,694 Commitment Shares and up to 10,000,000 shares issuable under a Securities Purchase Agreement. We will not receive any proceeds from Streeterville’s sales.
The public offering prospectus covers up to 1,133,652 shares issuable upon exercise of outstanding Series A warrants at an exercise price of $8.38 per share, expiring January 13, 2030.
The Streeterville facility permits Pre-Paid Purchases for an aggregate up to $20,000,000, including an initial $4,390,000 secured pre-paid purchase accruing 9% interest with a three-year maturity. Issuances are subject to a 9.99% beneficial ownership cap and Nasdaq Listing Rule 5635(d) limits. Common stock outstanding was 2,641,778 shares as of September 29, 2025 and, if all registered resale shares are issued, could be up to 12,641,778 shares. RIME last traded at $2.61 on September 29, 2025.
Algorhythm Holdings, Inc. (RIME) calls a virtual annual meeting on November 20, 2025 to vote on seven directors and several capital and governance proposals. The agenda includes: authorization for a reverse stock split at a ratio between 1-for-2 and 1-for-10, a reincorporation to Nevada, an amendment to the 2022 Equity Incentive Plan to raise authorized shares to 5,000,000, approval of potential share issuances to Streeterville Capital, LLC in pre-paid financings that may equal or exceed 20% of outstanding common stock, ratification of M&K CPAs as auditor, and potential adjournment.
Holders of record on September 29, 2025 may vote; 2,641,778 shares were outstanding as of the record date. For Proposal 5, 95,694 Streeterville “Commitment Shares” will be excluded from the Nasdaq-compliance tabulation. A quorum requires one-third of shares (33 1/3%). The reverse split is intended to help maintain Nasdaq’s $1.00 bid price standard, with implementation at the board’s discretion within one year of approval.
Algorhythm Holdings, Inc. (RIME)Scott Thorn. The filing states that no securities are beneficially owned as of 10/06/2025. This is a routine disclosure indicating the director held no reportable equity at the time of the event.
Algorhythm Holdings, Inc. changed its independent auditor. On October 6, 2025, the company dismissed Berkowitz Pollack Brant, Advisors + CPAs as its independent registered public accounting firm. Berkowitz had not issued any audit report on Algorhythm’s financial statements.
The company states there were no disagreements with Berkowitz on accounting principles, financial statement disclosure, or audit scope, and no reportable events other than previously disclosed material weaknesses in internal control over financial reporting. On the same date, Algorhythm engaged M&K CPAs PLLC as its new independent registered public accounting firm for the fiscal year ending December 31, 2025.
Algorhythm Holdings, Inc. (RIME) is soliciting proxies for its 2025 annual meeting to elect seven director nominees and to vote on several governance and corporate-structure proposals, including a reverse stock split, a proposed Nevada reincorporation, an amendment to the 2022 equity plan, a pre-paid transaction proposal, and ratification of M&K CPAs as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Stockholders can listen, submit questions and vote online at the provided portal; in-person attendance is not permitted. The filing discloses executive and director compensation tables showing total compensation figures by year (examples include $283,454 for one executive in Fiscal Year 2024 and $307,451 for Fiscal Year 2023 in certain tables), details on outstanding option awards with grant dates and exercise amounts, and board compensation practices such as a $25,000 annual cash retainer and a $25,000 annual stock option grant value for non-employee directors. The proxy states the board will determine timing for any Certificate of Amendment and may adjourn the meeting to solicit additional votes if proposals lack sufficient support.
Algorhythm Holdings, Inc. reported several leadership changes. On October 6, 2025, Scott Thorn and Kapil Gupta were appointed to the Board of Directors and assigned to key committees, including the audit committee for both, with Thorn also joining the compensation committee and Gupta the nominating and corporate governance committee. The Board cited their strategic, growth, and technology leadership experience as reasons for their selection.
On the same date, director Mathieu Peloquin resigned from the Board, with the company stating his departure was not due to any disagreement over operations, policies, or practices. Separately, on August 21, 2025, Chief Revenue Officer Bernardo Melo was terminated from that officer role, also not due to any such disagreements, and he will continue to serve as a member of the Board.
Algorhythm Holdings, Inc. (RIME) filed a Form S-1 registering the resale of up to 10,095,694 shares of common stock by Streeterville Capital, including 95,694 commitment shares and up to 10,000,000 shares that may be issued under a pre-paid purchase facility.
The filing also includes a public offering prospectus for up to 1,133,652 shares issuable upon exercise of outstanding Series A warrants at $8.38 per share, which are currently exercisable and expire on January 13, 2030.
Under the Securities Purchase Agreement dated August 21, 2025, the Company may complete pre-paid purchases up to $20,000,000. An initial pre-paid purchase of $4,390,000 (9% interest, three-year maturity) was funded, subject to an original issue discount and expenses. Issuances to Streeterville are limited by a 9.99% beneficial ownership cap and Nasdaq Listing Rule 5635(d) (Exchange Cap) until shareholder approval is obtained. RIME will not receive proceeds from Streeterville’s resales.
Common stock outstanding was 2,641,778 shares as of September 29, 2025; the table shows up to 12,641,778 shares outstanding immediately after the resale.
Algorhythm Holdings, Inc. filed an amended current report to add detailed financial information for its recently acquired Indian subsidiary, SMCB Solutions Private Limited. Through its subsidiary SemiCab Holdings, LLC, the company completed an Equity Purchase Agreement on May 2, 2025, buying 9,999 equity shares of SMCB with Rs. 10 par value, representing 99.99% of SMCB’s outstanding equity. The amendment supplies audited balance sheets and audited statements of operations, shareholders’ equity and cash flows for SMCB for the years ended March 31, 2025 and 2024, along with unaudited pro forma combined financial statements showing how SMCB would affect Algorhythm’s results. These exhibits give investors a clearer picture of the acquired business and how it fits into Algorhythm’s consolidated financials.
Algorhythm Holdings, Inc. entered into a sizable, secured equity-linked financing with Streeterville Capital, LLC. The company can raise up to
The facility includes a two-year period during which Algorhythm may request additional pre-paid purchases of at least